APA

Ryan P. C., Jakubczak J. L., Stewart D. A., Hawkins L. K., Cheng C., Clarke L. M., Ganesh S., Hay C., Huang Y., Kaloss M., Marinov A., Phipps S. S., Reddy P. S., Shirley P. S., Skripchenko Y., Xu L., Yang J., Forry-Schaudies S. & Hallenbeck P. L. (20050203). Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. : Cancer gene therapy.

Chicago

Ryan Patricia C, Jakubczak John L, Stewart David A, Hawkins Lynda K, Cheng Cheng, Clarke Lori M, Ganesh Shanthi, Hay Carl, Huang Ying, Kaloss Michele, Marinov Anthony, Phipps Sandrina S, Reddy P Seshidhar, Shirley Pamela S, Skripchenko Yelena, Xu Ling, Yang Jingping, Forry-Schaudies Suzanne and Hallenbeck Paul L. 20050203. Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. : Cancer gene therapy.

Harvard

Ryan P. C., Jakubczak J. L., Stewart D. A., Hawkins L. K., Cheng C., Clarke L. M., Ganesh S., Hay C., Huang Y., Kaloss M., Marinov A., Phipps S. S., Reddy P. S., Shirley P. S., Skripchenko Y., Xu L., Yang J., Forry-Schaudies S. and Hallenbeck P. L. (20050203). Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. : Cancer gene therapy.

MLA

Ryan Patricia C, Jakubczak John L, Stewart David A, Hawkins Lynda K, Cheng Cheng, Clarke Lori M, Ganesh Shanthi, Hay Carl, Huang Ying, Kaloss Michele, Marinov Anthony, Phipps Sandrina S, Reddy P Seshidhar, Shirley Pamela S, Skripchenko Yelena, Xu Ling, Yang Jingping, Forry-Schaudies Suzanne and Hallenbeck Paul L. Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. : Cancer gene therapy. 20050203.